Noel Warfel

Has grant

Assistant Professor

University of Arizona

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Targeting PIM kinases in Nrf2-driven NSCLC

Open Date: 2017-07-01

Close Date: 2018-06-01

Grant: Close

Targeting PIM kinases to oppose hypoxia-driven therapeutic resistance

Open Date: 2017-01-01

Close Date: 2020-12-01

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Christopher Prevost

University of Rochester

UNITED STATES

View details

Pedro Torres-Ayuso

Assistant Professor

Lewis Katz School of Medicine at Temple University

UNITED STATES

View details

Ghassan Mouneimne

UNITED STATES

View details

Lauren Ball

Director, Mass Spectrometry Facility; Associate Professor

Medical University of South Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Noel Warfel

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion

PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer.

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins.

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy

Targeting mitochondrial dynamics to overcome therapeutic resistance

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28

Optimized in vitro three-dimensional invasion assay for quantifying a wide range of cancer cell invasive behavior.

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α.

Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors

Collaborators (4)

Christopher Prevost

Pedro Torres-Ayuso

Ghassan Mouneimne

Lauren Ball

Make your next move.